|
Stealth Adapted Viruses. Another
Inconvenient Truth
The following excerpt is from the talk by Dr. W. John Martin, MD PhD,
at a Conference "Autism Hope and Treatment," held in Madera CA, March
30-31, 2007. Dr. Martin is Director of the Institute of Progressive
Medicine.
The talk began with an overview history of poliomyelitis and the
development of polio vaccines. It identified several missteps in this process
including the decision to use freshly cultivated kidney cells from
monkeys, rather than a well characterized cell line, for vaccine
production. The issue of SV40 contamination of vaccines produced in kidney cells
of rhesus monkeys led to a switch in 1961 to the use of African green
monkeys. In 1972 it was realized that African green monkey kidney cell
cultures were commonly contaminated with simian cytomegalovirus (SCMV).
Industry and the Food and Drug Administration (FDA) chose not to make
this information public arguing that many millions of doses had been
used without signs of an acute CMV illness. The possibility of SCMV
causing chronic illness was seemingly not considered even though other
viruses were known at the time to become latent in the body.
In 1991, Dr. Martin isolated a cell damaging virus from a patient
with the chronic fatigue syndrome (CFS). The virus was shown to be an
atypical CMV and, unequivocally, to have been derived from SCMV. The FDA
and the Centers for Disease Control and Prevention (CDC) were notified
of this finding with the clear inference that the virus probably came
from a contaminated polio virus vaccine. The virus caused a severe
illness in cats without evoking any inflammatory reaction; the usual
hallmark of an infectious disease. Dr. Martin reasoned that the virus had
possibly lost or mutated the relatively few viral genes that provide the
major target antigens for the cellular immune response. An analogy is a
terrorist who avoids homeland security by not wearing military insignia.
The terrorist can still cause extensive damage, as can viruses that go
unseen by the cellular immune system. Dr. Martin introduced the terms
"stealth" and "stealth adapted" to characterize a generic grouping of
viruses lacking components for effective immune recognition. Many
patients with complex neurological and psychiatric diseases were shown by
blood cultures to be infected with stealth adapted viruses, some of which
were unequivocally derived from SCMV. As predicted, DNA sequencing of
the stealth SCMV virus confirmed the loss or mutation of the three major
genes that code for antigens normally targeted by the cellular immune
system.
The FDA and CDC were unwilling or unable to accept the concept of
stealth adaptation and have seemingly been hesitant to criticize
vaccines. By 1998, however, the decision was made to switch from using live
polio virus vaccines (Sabin type) back to formalin inactivated killed
polio vaccine (Salk type). Finally in 2002, FDA did examine older lots of
polio virus vaccines for DNA of SCMV. Three of 8 lots from the
mid-1970's clearly contained SCMV DNA. More extensive and similarly positive
results were obtained in British studies on their vaccines.
Human CMV is the most common infectious cause of infant deaths in
the United States, far exceeding that of infant AIDS (400 vs. _50).
Moreover, it is a common cause of mental retardation and/or hearing and
visual impairment, with an estimated 8,000 children affected annually.
Congenital CMV has been linked to several cases of autism. It is negligence
that FDA and CDC have not followed up on the finding of SCMV DNA
contamination to screen some of these children to determine if their CMV is
always of human and not simian origin. FDA has simply argued that they
could not culture virus from these old vaccines and yet, for proprietary
reasons, can not provide the contaminated vaccines for independent
virus culture studies.
Dr. Martin has reported isolating stealth adapted viruses from
autistic children. Congenital infection is consistent with the biochemical
evidence of neurological damage at birth in children who subsequently
become autistic. A viral infection can cause the diverse symptoms seen in
autistic children and can explain some of the illnesses seen in other
family members, including mothers. An underlying viral infection would
also be expected to predispose an individual to heightened
susceptibility to various toxins and to be also influenced by various nutritional
and genetic factors.
Dr. Martin expressed criticism of the "business of autism" with the
selling of products and services at excessive profits; performing
irrelevant laboratory tests; and the over hyping of various supposed
therapies. Few specialists are well qualified to address autism as a
potentially infectious disease of the brain. Unfortunately, some practitioners
are also engaging in financial kick-backs with little regard for
rigorous science and clinical validation.
In spite of the absence of an effective immune response, the body is
able to counter stealth adapted viruses through an alternative cellular
energy (ACE) pathway. Indeed, autism can be simplified to a problem of
insufficient cellular energy for optimal brain functioning. Various
natural products with ACE activity are available for clinical trails.
In summary, Dr. Martin expressed his strong belief that i) stealth
adapted viruses exist and can explain the increasing incidence of many
types of diseases including autism. ii) That the body has an auxiliary
defense mechanism that extends beyond the immune system that can provide
cellular energy for healing. iii) Enhancing this alternative cellular
energy (ACE) pathway will be useful in the prevention and therapy of
autism. Additional information on this talk and copies of the presented
slides are available at www.s3support.com E-mail enquires are welcome at
s3support@mail.com
Please learn from our mistake and educate BEFORE you vaccinate!
For more information visit www.vacinfo.org or email VIC@vacinfo.org
|
